EyeGene Inc (185490) — Long-term Investment Intensity
EyeGene Inc (185490) has a Long-term Investment Intensity of 1.7% as of December 2019. Long-term investments of ₩794.96 Million represent 1.7% of total assets of ₩47.31 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check cash flow reinvestment rate of EyeGene Inc to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
EyeGene Inc Long-term Investment Intensity (2014–2019)
This chart shows how EyeGene Inc's Long-term Investment Intensity has evolved across 5 annual periods from 2014 to 2019. As of December 2019, the intensity stands at 1.7%, reflecting long-term investments of ₩794.96 Million against total assets of ₩47.31 Billion KRW. Explore 185490 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for EyeGene Inc (2014–2019)
The table below presents the year-by-year Long-term Investment Intensity for EyeGene Inc from 2014 to 2019, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see EyeGene Inc (185490) total market value.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 1.7% | ₩794.96 Million | ₩47.31 Billion | ▼ -0.9 pp |
| 2018 | 2.6% | ₩1.39 Billion | ₩54.04 Billion | ▼ -7.5 pp |
| 2017 | 10.1% | ₩3.06 Billion | ₩30.28 Billion | ▼ -5.0 pp |
| 2016 | 15.1% | ₩2.81 Billion | ₩18.56 Billion | ▲ +14.3 pp |
| 2014 | 0.8% | ₩45.75 Million | ₩5.54 Billion | — |